Clinical Trial Update: Methylphenidate in ADHD With Trichotillomania [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating methylphenidate for ADHD with trichotillomania. The current status of the study is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Trichotillomania

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Geha Mental Health Center | Conditions: ADHD, Trichotillomania | Phase 4 | Status: UNKNOWN